Structural basis for HLA-A2 supertypes

From Anna University to America and to Agriculture

Anna University (AU) is an awesome alma mater for attracting the attention of the invincible through awareness from education. It is a place with a plan for preparing a palace in a person's life. It is an avenue for America through adequate cGPA and Advanced GRE (AGRE) with good TOEFL score. The views,visions, modes and models of several faculty members shaped many technocrats, teachers, entrepreneurs, journalists, editors and even farmers. Technology is engineering with science. The foundation and facilities at AU is priceless. AU created the framework for Industrial Biotechnology, a truly inter disciplinary curriculum with an optimal blend of Engineering and Science (Biology especially Agriculture and Healthcare through Organic chemistry) in 1992 almost 28 years back. The place was positioned just perfect in the world for wonders to come true. The Raman auditorium (in reverence to the Nobel Laureate Sir CV Raman) reassured rational research with reasonable respect in many minds at the ACTECH (Alagappa College of Technology) under the administration of AU. The admiration, acknowledgement and accountability for the alma mater, the AU will always remain precious.

Short Peptide Vaccine Design and Development: Promises and Challenges

Vaccine development for viral diseases is a challenge where subunit vaccines are often ineffective. Therefore, the need for alternative solutions is crucial. Thus, short peptide vaccine candidates promise effective answers under such circumstances. Short peptide vaccine candidates are linear T-cell epitopes (antigenic determinants that are recognized by the immune system) that specifically function by binding human leukocyte antigen (HLA) alleles of different ethnicities (including Black, Caucasian, Oriental, Hispanic, Pacific Islander, American Indian, Australian aboriginal, and mixed ethnicities). The population-specific allele-level HLA sequence data in the public IMGT/HLA database contains approximately 12542 nomenclature defined class I (9437) and class II (3105) HLA alleles as of March 2015 present in several ethnic populations.

The bottleneck in short peptide vaccine design and development is HLA polymorphism on the one hand and viral diversity on the other hand. Hence, a crucial step in its design and development is HLA allele-specific binding of short antigen peptides. This is usually combinatorial and computationally labor intensive. Mathematical models utilizing structure-defined pockets are currently available for class I and class II HLA-peptide-binding peptides. Frameworks have been developed to design protocols to identify the most feasible short peptide cocktails as vaccine candidates with superantigen properties among known HLA supertypes. This approach is a promising solution to develop new viral vaccines given the current advancement in T-cell immuno-informatics, yet challenging in terms of prediction efficiency and protocol development.